financetom
Business
financetom
/
Business
/
What's Going On With Nordstrom Shares Thursday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Nordstrom Shares Thursday?
Sep 6, 2024 1:10 PM

Nordstrom, Inc. ( JWN ) shares are trading higher on Thursday. Goldman Sachs analyst Brooke Roach comments on the recent news of Nordstrom’s acquisition proposal by the Nordstrom ( JWN ) family and El Puerto de Liverpool.

On Wednesday, the Nordstrom ( JWN ) founding family made an offer to take the company private by acquiring all outstanding shares they do not already own for $23 per share in cash.

The Nordstrom ( JWN ) family group reportedly sent a non-binding letter to the special committee proposing a transaction that involves forming a new entity to buy the department store chain.

The Nordstrom ( JWN ) family had earlier made attempts to take the company private.

The recent effort comes about six years after the founding family’s previous attempt to take the U.S. department store operator private.

The analyst writes that real estate value is a key consideration, as evidenced by past department store transactions, such as the recently ended talks between Macy’s and an investor buyout group.

The analyst forecasts EPS of $1.98 in FY25, $2.05 in FY26, and $2.09 in FY27.

Last month, Nordstrom ( JWN ) reported quarterly earnings of 96 cents per share, which beat the analyst consensus estimate of 71 cents by 35.21%.

Investors can gain exposure to the stock via Invesco Exchange-Traded Fund Trust II Invesco S&P Ultra Dividend Revenue ETF and Invesco S&P Midcap 400 Pure Value ETF ( RFV ) .

Price Action: JWN shares are up 0.24% at $22.84 at the last check Thursday.

Read Next:

Goldman Sachs: Kamala Harris Victory Bodes Well For US Economy, Trump Tariffs Will Drive Up Inflation

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Intel, AMD Form Advisory Group to Advance x86 Computing Architecture
Intel, AMD Form Advisory Group to Advance x86 Computing Architecture
Oct 17, 2024
01:30 PM EDT, 10/15/2024 (MT Newswires) -- Intel ( INTC ) and AMD (AMD) on Tuesday announced the creation of an advisory group to advance the x86 computing architecture. The chipmakers said they would be joined by founding members Broadcom ( AVGO ) , Dell (DELL), Alphabet's (GOOG, GOOGL) Google ( GOOG ), HP (HPQ), Hewlett Packard Enterprise ( HPE...
Sector Update: Consumer
Sector Update: Consumer
Oct 17, 2024
01:32 PM EDT, 10/15/2024 (MT Newswires) -- Consumer stocks were rising Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.8% and the Consumer Discretionary Select Sector SPDR Fund (XLY) up 0.3%. Redbook US same-store sales rose 5.6% from a year earlier in the week ended Oct. 12, greater than the 5.4% increase in the previous week....
Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced
Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced
Oct 17, 2024
01:40 PM EDT, 10/15/2024 (MT Newswires) -- Rani Therapeutics Holdings ( RANI ) shares fell 23% in recent Tuesday trading after the company priced a registered direct offering of securities for gross proceeds of about $10 million. The company agreed to sell 3 million shares of class A common stock, prefunded warrants for 333,333 shares and series C common warrants...
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
Oct 17, 2024
Last week, Sanofi SA ( SNY )  said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business. The deal could be valued at about 15 billion euros ($16.4 billion), making it one of the largest European transactions this year. Sanofi ( SNY ) is likely to retain a minority stake in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved